Five-year treatment with Cosentyx (secukinumab) is safe and effective in easing signs and symptoms of ankylosing spondylitis (AS), according to results…
Marta Figueiredo
Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marta Figueiredo
Intravenous infusion of Simponi Aria (golimumab) significantly improves ankylosing spondylitis (AS) symptoms in adults, an ongoing Phase 3 trial…
UCBÂ biopharma’s experimental therapy bimekizumab (CDP-4940, UCB-4940) significantly improved ankylosing spondylitis (AS) symptoms after 12 weeks of…